Indomethacin
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76420-029 -
Package NDC
76420-029-01 -
Package NDC
76420-029-02 -
Package NDC
76420-029-07 -
Package NDC
76420-029-14 -
Application number
ANDA201807 -
SPL ID
ead13cff-b9d2-cdc1-e053-2a95a90adf09 -
SPL set ID
dfdcdb27-07a0-47e6-b8da-d9c99045a066 -
UNII
XXE1CET956 -
RxCUI
310992
What the source publishes
- Labeler
- Asclemed USA, Inc.
- Active ingredients
- Indomethacin
- Form
- CAPSULE, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Indomethacin",
"splId": "ead13cff-b9d2-cdc1-e053-2a95a90adf09",
"labels": [
{
"setId": "dfdcdb27-07a0-47e6-b8da-d9c99045a066",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=dfdcdb27-07a0-47e6-b8da-d9c99045a066",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=dfdcdb27-07a0-47e6-b8da-d9c99045a066"
}
],
"routes": [
"ORAL"
],
"labeler": "Asclemed USA, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-01)",
"package_ndc": "76420-029-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20200211"
},
{
"sample": false,
"description": "2 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-02)",
"package_ndc": "76420-029-02",
"identifierStatus": "well-formed",
"marketing_start_date": "20200211"
},
{
"sample": false,
"description": "7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-07)",
"package_ndc": "76420-029-07",
"identifierStatus": "well-formed",
"marketing_start_date": "20200211"
},
{
"sample": false,
"description": "14 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (76420-029-14)",
"package_ndc": "76420-029-14",
"identifierStatus": "well-formed",
"marketing_start_date": "20200211"
}
],
"productId": "76420-029_ead13cff-b9d2-cdc1-e053-2a95a90adf09",
"useDomain": "unknown",
"dosageForm": "CAPSULE, EXTENDED RELEASE",
"productNdc": "76420-029",
"deaSchedule": null,
"genericName": "Indomethacin",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "INDOMETHACIN",
"strength": "75 mg/1"
}
],
"applicationNumber": "ANDA201807",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20150724",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000000160",
"M0001335",
"N0000175722"
],
"unii": [
"XXE1CET956"
],
"rxcui": [
"310992"
],
"spl_set_id": [
"dfdcdb27-07a0-47e6-b8da-d9c99045a066"
],
"pharm_class_cs": [
"Anti-Inflammatory Agents, Non-Steroidal [CS]"
],
"pharm_class_epc": [
"Nonsteroidal Anti-inflammatory Drug [EPC]"
],
"pharm_class_moa": [
"Cyclooxygenase Inhibitors [MoA]"
],
"manufacturer_name": [
"Asclemed USA, Inc."
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76420-029_ead13cff-b9d2-cdc1-e053-2a95a90adf09"